MyFinsight
Home
Blog
About
Marketable securities
$358,274K
(3485.97%↑ Y/Y)
Cash and cash
equivalents
$107,855K
(-43.41%↓ Y/Y)
Prepaid expenses
$5,875K
(291.67%↑ Y/Y)
Other current assets
$3,103K
(591.09%↑ Y/Y)
Total current assets
$475,107K
(131.84%↑ Y/Y)
Operating lease
right-of-use assets
$2,718K
(11225.00%↑ Y/Y)
Other assets
$2,412K
(474.29%↑ Y/Y)
Property and equipment,
net
$648K
Restricted cash
$168K
Total assets
$481,053K
(134.24%↑ Y/Y)
Accumulated deficit
-$1,435,367K
(30.43%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$922K
(-6685.71%↓ Y/Y)
Total liabilities and
stockholders' deficit
$481,053K
(134.24%↑ Y/Y)
Total stockholders'
deficit
-$200,197K
(86.70%↑ Y/Y)
Additional paid-in capital
$1,236,073K
(121.75%↑ Y/Y)
Common stock, 0.0001
par value...
$19K
(46.15%↑ Y/Y)
Total liabilities
$681,250K
(-60.19%↓ Y/Y)
Warrant liabilities
$653,894K
(-60.43%↓ Y/Y)
Total current
liabilities
$24,814K
(-57.78%↓ Y/Y)
Operating lease
liabilities, less current...
$2,542K
Accrued liabilities
$20,481K
(-64.75%↓ Y/Y)
Accounts payable
$3,998K
(497.61%↑ Y/Y)
Operating lease
liabilities
$335K
Back
Back
Balance Sheet
Vor Biopharma Inc. (VOR)
Vor Biopharma Inc. (VOR)
source: myfinsight.com